Zynyz – Talk Bio

Actionable Insights Powered by AI

Incyte’s PD-1 Drug Zynyz: A Strategic Pipeline Component Despite Recent Trial Success

7 months ago talkbio0Tagged Approved, Clinical Trials, Incyte, Inhibitor, Malignant neoplasm of anus, PDCD1 gene, United States Food and Drug Administration, Zynyz

Incyte, Zynyz, PD-1 inhibitor, anal cancer, pipeline strategy, clinical trials, FDA approval

Incyte Reports Positive Results for PD-1 Inhibitor Zynyz in Two Phase 3 Clinical Trials

9 months ago talkbio0Tagged Carcinoma of anal margin, Incyte, Inhibitor, Non-Small Cell Lung Carcinoma, PDCD1 gene, Phase 3, Zynyz

Incyte, Zynyz, PD-1 Inhibitor, Phase 3 Clinical Trials, Squamous Cell Anal Carcinoma, Non-Small Cell Lung Cancer